
|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
Policy: Task Masters
Author(s)Kevin Gopal
London-Government and industry have agreed there should be no weakening of patent protection in the effort to speed access to medicines in the developing world.
Advertisement
Articles in this issue
about 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearabout 25 years ago
Friends of Complexityabout 25 years ago
Under Federal Fireabout 25 years ago
Task Force: Enter the Fixersabout 25 years ago
The Next Y2Kabout 25 years ago
Political ScienceAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
2
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
3
The New Healthy Aging Imperative and What It Means for Pharma
4
Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics
5




